Location History:
- Helsinki, FI (1998 - 2000)
- Brookline, MA (US) (2006)
- Boston, MA (US) (2004 - 2013)
Company Filing History:
2 out of 525 
1 out of 15 
1 out of 178 
Years Active: 1998-2013
Title: Arja Kaipainen: Innovator in Neoplastic Disease Research
Introduction
Arja Kaipainen is a prominent inventor based in Boston, MA, known for her significant contributions to the field of cancer research. With a total of five patents to her name, she has made remarkable strides in developing methods for screening neoplastic disease states.
Latest Patents
Among her latest patents, one notable invention is focused on methods of screening for neoplastic disease states. This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments thereof, along with polynucleotides encoding such polypeptides, antibodies that specifically bind to these polypeptides, and their various uses. Another significant patent involves using FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy, which also includes similar components as her previous invention.
Career Highlights
Throughout her career, Arja has worked with esteemed organizations such as the Ludwig Institute for Cancer Research Limited and Helsinki University Licensing, Ltd. Her work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Arja has collaborated with notable professionals in her field, including Kari Alitalo and Olga Aprelikova, who have contributed to her research endeavors.
Conclusion
Arja Kaipainen's innovative work in cancer research and her patented inventions highlight her dedication to improving methods for diagnosing and treating neoplastic diseases. Her contributions continue to impact the scientific community and pave the way for future advancements in cancer therapy.